EPAZ: A randomized phase II trial comparing pazopanib with doxorubicin as first line treatment in elderly patients with metastatic or advanced soft tissue sarcoma of the Working Group Medical Oncology (AIO) and German Interdisciplinary Sarcoma Group (GISG)

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 33; no. 15_suppl; p. TPS10576
Main Authors Gruenwald, Viktor, Kunitz, Annegret, Schuler, Markus Kajo, Kopp, Hans-Georg, Kasper, Bernd, Lindner, Lars, Chemnitz, Jens-Marcus, Stein, Alexander, Schöffski, Patrick, Steffen, Bjoern, Bauer, Sebastian, Egerer, Gerlinde, Kneba, Michael, Crysandt, Martina, Koch, Armin
Format Journal Article
LanguageEnglish
Published 20.05.2015
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2015.33.15_suppl.tps10576